Patents by Inventor Dafna Arieli

Dafna Arieli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170011614
    Abstract: The disclosure relates to methods and systems used to locate eyeglasses. Specifically, the disclosure relates to systems of components configured to provide a user with the location of the glasses.
    Type: Application
    Filed: June 3, 2016
    Publication date: January 12, 2017
    Inventor: Dafna Ariely
  • Publication number: 20140313033
    Abstract: A system for locating an item, comprising a locator device, the locator device comprises at least a receiver, an alarm module and a connector to attach the locator device to an item; and a transmitter to generate a pre-selected signal to be received by the receiver once the receiver is within a reception range from said transmitter, wherein the receiver is to actuate the alarm module once the pre-selected signal is received.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 23, 2014
    Inventor: Dafna Ariely
  • Publication number: 20130189358
    Abstract: The present invention includes a compressed solid dosage form comprising saxagliptin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient, wherein the at least one pharmaceutically acceptable excipient optionally comprises at least one organic acid.
    Type: Application
    Filed: January 10, 2013
    Publication date: July 25, 2013
    Inventors: Roey SOLOMONOVICH, Dafna ARIELI
  • Publication number: 20130064888
    Abstract: The present invention provides a pharmaceutical dosage form in the form of a tablet comprising: (a) a compressed inert core, (b) an optional subcoat over the compressed inert core, (c) a drug layer over the compressed core (a) or optional subcoat (b) comprising a drug having a water solubility at 25° C. of about 100 mg/l or less, a coating polymer and optionally a surfactant, and (d) optionally one or more layers coating the drug layer. The present invention also provides a process of making the same.
    Type: Application
    Filed: August 8, 2012
    Publication date: March 14, 2013
    Inventors: Roey SOLOMONOVICH, Dafna ARIELI
  • Publication number: 20120301541
    Abstract: A compressed core for a pharmaceutical dosage form comprising a mixture of (a) at least one pharmaceutically acceptable organic acid, and (b) at least one pharmaceutically acceptable excipient is described. Such compressed core is useful for the preparation of pharmaceutical compositions containing a drug in which dissolution of the drug is favored in acidic environments. Also described are pharmaceutical compositions comprising such compressed core.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Inventors: Elina HARONSKY, Dafna Arieli
  • Publication number: 20110086102
    Abstract: The present invention provides delayed release pharmaceutical compositions comprising an active pharmaceutical ingredient, e.g. mycophenolate sodium, and an enteric polymer, and methods for preparing the same. Preferably, the pharmaceutical compositions do not contain a coating.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 14, 2011
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: David Isaac SILVER, Julia Hrakovsky, Roey Solomonovich, Dafna Arieli
  • Publication number: 20100055177
    Abstract: Provided are modified release levetiracetam compositions, and processes for preparing them.
    Type: Application
    Filed: August 28, 2009
    Publication date: March 4, 2010
    Inventors: Dafna Arieli, Orly Grinberg, Roey Solomonovich
  • Publication number: 20080050449
    Abstract: The invention encompasses stable multiparticulate pharmaceutical compositions of tolterodine having at least one pharmaceutically acceptable excipient and at least two populations of multiparticulates each population having tolterodine or a salt thereof and the ratio of the populations is from 90:10 to 10:90 by weight, wherein after storage for 1 month at 40° C. and 75% relative humidity the difference between the dissolution profile at 4 hours is no more than about 5% when compared to the dissolution profile at the time of manufacture.
    Type: Application
    Filed: March 21, 2007
    Publication date: February 28, 2008
    Inventors: Dafna Arieli, Tomer Gold